ea0073aep730 | Thyroid | ECE2021
Tordjman Karen
, Bishouty Nancy
, Greenman Yona
BackgroundIntravenous levothyroxine (IVT4) is FDA-approved for the treatment of myxedema coma (ME). We noticed that at our hospital, IVT4 is administered more frequently than expected.Aim of studyTo assess the extent of IVT4 administration, the indications for such a treatment, and its outcome at a tertiary facility.MethodsA retrospective study of IVT4 administere...